explore -WSS

explore

author：fashion 2025-10-02 13:41:11 - browse：5

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Anesthesiologist group: stop taking Ozempic before surgery

WSS

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

In age of alternative facts, a scholarly course on calling out crap

Medicare details structure of new drug price negotiation program

BioMarin wins approval for gene therapy to treat hemophilia A

Novavax promises a turnaround & Lilly roils the obesity market

Peter Hotez and the public health issue of online harassment

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Shifting the focus from loneliness to social health

Sports medicine is finally prioritizing gender equality

Psychedelics group wrestles with new pharma identity

Jerome Adams on the need for new antivirals for Covid

Anesthesiologist group: stop taking Ozempic before surgery

How one medical school became remarkably diverse

Letters to First Opinion on caregivers, digital health, and more

Bright Health sells Medicare Advantage business to Molina

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wikipedia

Intellia reports positive results for its CRISPR

At least 13 dead in Texas as scorching temps continue

Cord blood banking comes at a high cost to babies

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Change Healthcare can notify patients about the breach, HHS says

explore

Wikipedia

explore

Wikipedia